CDEK
← All drugs Report issue

bnt162b2

Trade name: Comirnaty

Vaccineexperimental

Clinical trial activity

133 trials · 180 clinical orgs · 0 marketing orgs

Phase 1
20
Phase 2
88
Phase 3
41
Phase 4
27

Earliest trial started Apr 23, 2020 (NCT04380701)

Timeline

2020s

  1. Jan 1, 2020

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2020

    Earliest Phase 2 Sponsor(trial)

  3. Jan 1, 2021

    Earliest Phase 3 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07280858Phase 1/Phase 2 (Phase 2)Jan 6, 2026SK Bioscience Co., Ltd.
NCT07300839Phase 3Dec 10, 2025Biontech, Pfizer
NCT07287137Phase 4Nov 12, 2025Centers for Disease Control and Prevention (CDC), Food and Drug Administration, Henry M. Jackson Foundation for the Advancement of Military Medicine, Uniformed Services University of the Health Sciences
NCT07222384Phase 3Oct 30, 2025Biontech, Pfizer
NCT06810934Phase 1/Phase 2 (Phase 2)Oct 21, 2025National Institute of Allergy and Infectious Diseases (NIAID), University of California, Davis, University of California, Los Angeles, University of California, San Francisco
NCT07051031Phase 4Oct 1, 2025Oregon Health and Science University
NCT07069309Phase 3Jul 8, 2025Biontech, Pfizer
NCT06919796Phase 2May 1, 2025Emory University, PharmaJet, Inc.
NCT06742281Phase 2Dec 5, 2024CyanVac LLC, Department of Health and Human Services
NCT06587503Phase 4Oct 31, 2024Merck, Rwanda Biomedical Centre, University of Birmingham
NCT06672055Phase 2Oct 8, 2024Vaxart
NCT06633835Phase 4Sep 20, 2024Novavax, University of Utah
NCT06503900Phase 4Sep 12, 2024Boston University, Centers for Disease Control and Prevention (CDC), Duke University, Emory University, Wake Forest University
NCT06452654Phase 4May 8, 2024Gottfried Wilhelm Leibniz Universität Hannover, Helmholtz Centre for Infection Research, Katholieke Universiteit Leuven, Lund University, Newcastle University, Technical University of Dresden, Technical University of Munich, University of Birmingham, University of Cambridge
NCT06237049Phase 2Jan 31, 2024Pfizer
NCT06178991Phase 3Dec 21, 2023Biontech, Pfizer
NCT06065176Phase 4Nov 22, 2023Novavax, University of Utah, Westat
NCT06181292Phase 2/Phase 3 (Phase 3)Nov 13, 2023Laboratorios Hipra, S.A.
NCT05911048Phase 2Oct 30, 2023Government of China
NCT06038617Phase 4Oct 30, 2023Centers for Disease Control and Prevention (CDC), Columbia University, Duke University, Kaiser Permanente, University of Cincinnati
Showing 20 of 133 trials
Page 1 / 7

Organizations

Research & Development (180)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
BiontechFor profit232232020
PfizerFor profit19322020
National Institute of Allergy and Infectious Diseases (NIAID)Government8622021
Coalition for Epidemic Preparedness InnovationsAcademic/Hospital6022022
Sinocelltech Ltd.For profit6612022
Assistance Publique - Hôpitaux de ParisAcademic/Hospital5532021
Duke UniversityAcademic/Hospital5322021
Murdoch UniversityAcademic/Hospital5522022
Centers for Disease Control and Prevention (CDC)Government4012021
COVIREIVACAcademic/Hospital4022021
Laboratorios Hipra, S.A.For profit4422021
NovavaxFor profit4322023
The Peter Doherty InstituteAcademic/Hospital4012022
The University of Hong KongAcademic/Hospital4422021
Emory UniversityAcademic/Hospital3022021
Johns Hopkins UniversityAcademic/Hospital3022021
Autonomous University of MadridAcademic/Hospital2012021
Butantan InstituteAcademic/Hospital2112022
Chulalongkorn UniversityAcademic/Hospital2012021
FosunFor profit2022020
180 organizations
Page 1 / 9